digestive enzymes and semaglutide Is Oral a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective Semaglutide for Weight Loss FAQ's
Description
During the consultation appointment, the patient and their provider will discuss their goal weight, medical history, and lifestyle
In mazdutides GLORY-2 trial, GI events were mostly mild to moderate, and 2.9% of participants discontinued treatment due to adverse events, versus none in the placebo group
We also acknowledge INSERM (to DC) and Agence Nationale de la Recherche (ANR-21-CE14-0018 to D.C.)
PMID 32994865
